MYX 0.66% $4.60 mayne pharma group limited

Ann: Change of Director's Interest Notice, page-22

  1. 924 Posts.
    lightbulb Created with Sketch. 336
    MYX shares will go up in value. The current and future product line is in womens health and skin care issues. Womens health in particular wont go away in a depression/recession. MYX has a good business model. Management will improve the costs and it will succeed long term. Its not a hyped up tech company selling access to software - whose shares can dive 95%. The company has a great market and great opportunity. Its debt free with some cash to invest wisely... Opportunities may present themselves with more hormonal treatments for women from Mithra. No more generics !!! No more debt !!!! the mistakes of the teva purchase have been written out of the equation.... Business takes time to happen - just be patient.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.